REMBRANDT Team Awarded Service Medal
NCI Listens and Learns
|NCI would like to know:|
|1. ||What steps should a person looking to join a cancer treatment trial take to find the right trial? Where or to whom should they go for information?|
|2.||The NCI Web site features a "How to Find a Cancer Treatment Trial" guide. NCI would appreciate feedback about the guide's usefulness and relevance.|
Please visit the guide and tell NCI:
- Are the steps sufficiently "actionable?" Does the guide empower users to perform the tasks to find a trial?
- What specific improvements should be made to the guide?
- Should this guide be recommended to others?
Go to http://ncilistens.cancer.gov to register and post your comments.
Dr. Subhashree Madhavan of NCI's Center for Bioinformatics and her colleagues on the REMBRANDT Project received a 2005 Service to America Medal ("Sammie"). They were honored in the category of Science and Environment for developing a national database that will house molecular and genetic data on all types of brain tumors, including information from an NCI clinical study and a vast store of existing information on brain tumors. Conducted in partnership with the National Institute of Neurological Disorders and Stroke, REMBRANDT (REpository for Molecular BRAin Neoplasia DaTa) supports analysis of clinical and molecular datasets from the Glioma Molecular Diagnostic Initiative, a brain tumor study spearheaded by Dr. Howard Fine of NCI's CCR. The Sammies were created in 2002 to recognize the finest achievements of public servants across the country. The medal was awarded on September 28.
Nancy G. Brinker Receives 2005 Lasker Public Service Award
Nancy G. Brinker was awarded the 2005 Lasker Public Service Award on September 18 for creating the Susan G. Komen Breast Cancer Foundation and increasing public awareness about a disease that was once talked about only in whispers and rarely in public. With just $200, Ms. Brinker started the Komen foundation in 1982, 2 years after her sister, Susan Komen, had died of breast cancer at age 36. Today the foundation has more than 75,000 volunteers and has raised more than $740 million to support breast cancer research, education, screening, and treatment. Hundreds of thousands of runners participate in its annual "Race for the Cure," and breast cancer is now understood by the public to be one of the leading causes of death in women. Ms. Brinker started and "nurtured the grass-roots breast cancer advocacy movement," the Lasker Foundation said. Now 58, Ms. Brinker is also a breast cancer survivor.
NCI Funds Centers of Cancer Nanotechnology Excellence
NCI has established seven Centers of Cancer Nanotechnology Excellence (CCNEs) and awarded them a total of $26.3 million in the first year. CCNEs are multi-institutional hubs that focus on integrating nanotechnology into basic and applied cancer research to develop new tools for preventing, diagnosing, detecting, and treating cancer. Each of the CCNE awardees is associated with one or more NCI-designated Cancer Centers, is affiliated with schools of engineering and physical sciences, and is partnered with nonprofit organizations or private sector firms with the intent of advancing the technologies being developed. Nanotechnology is the development and engineering of devices so small that they are measured on a molecular scale. The establishment of these Centers of Excellence is one of four major program components of the NCI Alliance for Nanotechnology in Cancer, a $144.3 million, 5-year initiative launched in 2004. For a list of the CCNEs, go to http://nano.cancer.gov.
Weingarten Joins OTIR as Small Business Program Manager
Michael Weingarten recently joined NCI's Office of Technology and Industrial Relations as small business program manager. As such, he will lead program activities of the Center for Strategic Scientific Initiatives, including policy development and management of NCI's small business programs and strategic partnerships. Before joining NCI, Mr. Weingarten worked for more than 14 years at the National Aeronautics and Space Administration, most recently as a manager in the Exploration Systems Research and Technology Program, where he led a team of experts in forging partnerships with the biomedical industry to develop technologies with implications for national public health.